The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Improving population health and health equity by connecting leaders with experience and sound evidence
Learn More
Read More
Blog Post
Jul 2, 2025
Publication
Jun 30, 2025
Jun 24, 2025
News Article
Jun 23, 2025
Jun 20, 2025
Current Issue Early View Opinions
Early View Perspective
By: Hannah L.F. Cooper, Anna L. Mullany, Snigdha Peddireddy, Simone Wien, Melvin "Doug" Livingston, Whitney S. Rice, Anne L. Dunlop, Michael R. Kramer, Madison Haiman, Lasha S. Clarke, Natalie D. Hernandez-Green, Angélica Meinhofer,
See all articles in the special issue, Mental Health and Substance Use Challenges Facing the United States: What Can State Policymakers… More
By: Gabriela Plasencia, Kamaria Kaalund, Olurotimi Kukoyi, Viviana Martinez-Bianchi, Andrea Thoumi,
Populations that identify as Latino/a/e/x or Hispanic (herein referred to as Latine) in the United States continue to face disproportion-ate health… More
By: Noa Krawczyk, Hillary Samples,
The United States is facing an ongoing mental health and substance use crisis. In 2023, 58.7 million US adults had a past-year mental illness, 46.3 million had a substance use disorder (SUD), and 20.4 million had both. More
By: Hannah Rahim, Aaron S. Kesselheim,
Prescription drug prices in the United States are substantially higher than in other high-income countries, with US prices reported to be an average of 2.78 times those of other countries in the Organisation for Economic Co-operation and Development.1 In response to these high prices, along with an opaque supply chain that can lead to substantial discrepancies in prices across different payors, states have passed drug price transparency laws that require manufacturers to disclose information on drug prices. More
By: MATTHEW S. McCOY, MARTHA E. GAINES, STEVEN JOFFE, Genevieve Pham-Kanter, EMILY A. LARGENT, Bernard Lo, HOLLY FERNANDEZ LYNCH, ALLISON M. WHELAN, Michelle M. Mello,
Leaders at many of the country’s top academic medical centers earned—in addition to their institutional salaries—hundreds of thousands of dollars a year as directors of pharmaceutical and device companies. Critics have urged academic institutions to rethink conflict of interest policies governing leaders’ outside activities, which are understood to pose not only individual conflicts for leaders themselves but also institutional conflicts for their academic employers. More
By: Magdalena Cerdá, DANIEL B. NEILL, ELLICOTT C. MATTHAY, JOHNATHAN A. JENKINS, BRANDON D. L. MARSHALL, Katherine Keyes,
People in the United States are dying at record numbers from overdose. Overdose deaths increased from fewer than 17,000 deaths in 1999 to an estimated 100,000 deaths approximately 25 years after, with a peak of almost 108,000 deaths in 2022. Racial/ethnic minoritized groups are now particularly affected: in 2023, the highest rates of overdose were among non-Hispanic Black and American Indian/Alaska Native Americans. Although overdoses increasingly involve both opioids and stimulants, opioids contribute to over three-quarters of all overdose deaths, primarily driven by illegally manufactured synthetic opioids like fentanyl. More
Jerel M. Ezell
Sugy Choi
Jamila Michener
Sarah E. Gollust
Thom Walsh
See All Opinions
The Peterson-Milbank Program for Sustainable Health Care Costs advances state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank State Leadership Network is a bipartisan group of state health policy leaders from both the executive and legislative branches.
The Emerging Leaders Program seeks to develop practical, hands-on leadership skills in future senior executive and legislative officials.
The Milbank Fellows Program is a leadership program for executive branch and senior legislative state government leaders committed to improving population health.
Keep up with news and updates from the Milbank Memorial Fund.
Short takes from Milbank Memorial Fund staff and guest authors on research and policies that affect population health.
Milbank Memorial Fund President Christopher Koller and other staff offer their perspectives on both the latest and perennial issues in population health.